Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00574132
Other study ID # ELN115727-301
Secondary ID
Status Completed
Phase Phase 3
First received December 10, 2007
Last updated October 30, 2013
Start date December 2007
Est. completion date June 2012

Study information

Verified date October 2013
Source JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug AdministrationCanada: Health CanadaAustria: Austrian Agency for Health and Food Safety (AGES)Germany: Paul-Ehrlich-Institut (PEI)
Study type Interventional

Clinical Trial Summary

This is a multicenter, double-blind, placebo controlled, randomized, outpatient multiple dose study in male and female patients ages 50 to less than 89 years with mild to moderate AD. Approximately 230 study sites in the US and Canada and up to 35 sites outside of North America will be involved. Patients will be randomized to receive either bapineuzumab or placebo. Each patient's participation will last approximately 1.5 years.

Bapineuzumab is a humanized monoclonal antibody, which binds to and clears beta amyloid peptide, and is designed to provide antibodies to beta amyloid directly to the patient.


Recruitment information / eligibility

Status Completed
Enrollment 1331
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Both
Age group 50 Years to 88 Years
Eligibility Inclusion Criteria:

- Diagnosis of probable AD

- Age from 50 to less than 89

- Mini-Mental Status Exam score of 16-26 inclusive

- Brain magnetic resonance imaging (MRI) scan consistent with the diagnosis of AD

- Stable doses of medications (cholinesterase inhibitors and memantine allowed)

- Caregiver able to attend all clinic visits with patient

Exclusion Criteria:

- Significant neurological disease other than AD

- Major psychiatric disorder

- Significant systemic illness

- History of stroke or seizure, autoimmune disease, myocardial infarction within the last 2 years

- Smoking greater than 20 cigarettes per day

- Anticonvulsants, anti-Parkinson's, anticoagulant, or narcotic medications

- Prior treatment experimental immunotherapeutics or vaccines for AD

- Women of childbearing potential

- Presence of pacemakers, CSF shunts, or foreign metal objects in the eyes, skin or body

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Bapineuzumab 0.5 mg/kg
infusion every 13 weeks for a total of 6 infusions
Placebo Control
given by infusion every 13 weeks for a total of 6 infusions.
Bapineuzumab 1.0 m/kg
infusion every 13 weeks for a total of 6 infusions

Locations

Country Name City State
Austria Medizinische Universität Graz Graz Styria
Austria Medizinische Universität Wien Wien Vienna
Canada University of Calgary, Foothills Medical Centre Calgary Alberta
Canada Neuro Rive-Sud Memory Clinic Greenfield Park Quebec
Canada Medical Arts Health Research Group Kamloops British Columbia
Canada Medical Arts Health Research Group Kelowna British Columbia
Canada Hotel Dieu Hospital/Queens University Memorial Clinics Kingston Ontario
Canada Parkwood Hospital London Ontario
Canada Saint Joseph's Health Care London, Saint Joseph's Hospital London Ontario
Canada Hopital Maisonneuve-Rosemont, Comite d' ethique de la recherche Montreal Quebec
Canada Jewish General Hospital Montréal Quebec
Canada Bruyere Continuing Care Ottawa Ontario
Canada Medical Arts Health Research Group Penticton British Columbia
Canada Kawartha Regional Memory Clinic Peterborough Ontario
Canada Diex Research Sherbrooke Inc. Sherbrooke Quebec
Canada Neurology Research Inch./Toronto Memory Program Toronto Ontario
Canada Toronto Centre for Memory and Aging Toronto Ontario
Canada University of British Columbia (UBC) Hospital Vancouver British Columbia
Canada Douglas Mental Health University Institute Verdun Quebec
Canada Ontario Shores Centre for Mental Health Scienes Whitby Ontario
Germany Saint Josefs Hospital Bochum Nordrhein-westfalen
Germany ABX-CRO advanced pharmaceutical services Forschungsgesellschaft GmbH Dresden Saschen
Germany Universitätsklinik Freiburg Freiburg Baden-Württemberg
Germany Universitätsklinikum Ulm Günzburg Bayern
Germany UKE Hamburg Hamburg
Germany Universitätsklinikum des Saarlandes Homburg/Saar Saarland
Germany AFL Arzneimittelforschung Leipzig GmbH Leipzig Sachen
Germany Klinikum Rechts der Isar der Technischen Universität München München Bayern
Germany Ludwig-Maximilians-Universität München München Bayern
Germany Universitätsklinikum Regensburg Regensburg Byern
Germany Universitätsklinik Tübingen Tübingen Baden-wuerttemberg
Germany Universitätsklinik Ulm Ulm Baden-wuerttemberg
United States Abington Neurological Associates, Ltd Abington Pennsylvania
United States Neurological Associates of Albany, P.C. Albany New York
United States Neuroscience Research Center at Albany Medical Center Albany New York
United States Upstate Clinical Research, LLC Albany New York
United States Albuquerque Neuroscience, Inc. Albuquerque New Mexico
United States University of New Mexico, Health Sciences Center Albuquerque New Mexico
United States Innovative Clinical Research Center Alexandria Virginia
United States Lehigh Valley Health Network Allentown Pennsylvania
United States University of Michigan Ann Arbor Michigan
United States Emory University/School of Medicine Atlanta Georgia
United States MS Center of Atlanta Atlanta Georgia
United States NeuroTrials Research, Inc. Atlanta Georgia
United States JEM Research, LLC Atlantis Florida
United States Senior Adults Specialty Research (SASR) Austin Texas
United States Johns Hopkins School of Medicine Baltimore Maryland
United States University of Maryland Baltimore Maryland
United States Rakesh Ranjan, M.D. & Associates, Inc. Beachwood Ohio
United States McLean Hospital Belmont Massachusetts
United States The Memory Clinic Bennington Vermont
United States East Bay Physicians Medical Group Berkeley California
United States Comprehensive Clinical Research Berlin New Jersey
United States Deaconess Billings Clinical Research Center Billings Montana
United States University of Alabama Hospital (UAB) Birmingham Alabama
United States Boston University School of Medicine Boston Massachusetts
United States Brigham and Women's Hospital Boston Massachusetts
United States Alpine Clinical Research Center Boulder Colorado
United States Bradenton Research Center, Inc Bradenton Florida
United States Social Psychiatry Research Institute Brooklyn New York
United States Fletcher Allen Health Care Burlington Vermont
United States Neuro-Behavioral Clinical Research, Inc Canton Ohio
United States NeuroCare Center, Inc Canton Ohio
United States AVI Clinical Research Carson California
United States Five Towns Neuroscience Research Cedarhurst New York
United States University of Virginia Charlottesville Virginia
United States Northwestern University Feinberg School of Medicine Chicago Illinois
United States University of Chicago Medical Center Chicago Illinois
United States University Memory and Aging Center University Hospitals of Cleveland/Case Medical Center Cleveland Ohio
United States Medical Research and Health Education Foundation, Inc. Columbus Georgia
United States Ohio State University Columbus Ohio
United States Neurology Clinic, PC Cordova Tennessee
United States ATP Clinical Research, Inc Costa Mesa California
United States Texas Neurology, PA Dallas Texas
United States University of Texas Southwestern Medical Center at Dallas Dallas Texas
United States Associated Neurologists, PC Danbury Connecticut
United States Neurology Specialists, Inc. Dayton Ohio
United States Dekalb Neurology Associates Decatur Georgia
United States Quantum Laboratories, Inc. Deerfield Beach Florida
United States Brain Matters Research, Inc. Delray Beach Florida
United States Mile High Research Center Denver Colorado
United States InSite Clinical Research DeSoto Texas
United States Henry Ford Hospital Detroit Michigan
United States Coastal Neurology, PA Dover New Hampshire
United States Duke University Medical Center Durham North Carolina
United States Michigan State University East Lansing Michigan
United States Rhode Island Mood and Memory Research Institute East Providence Rhode Island
United States The Memory Enhancement Center of America, Inc. Eatontown New Jersey
United States Alexian Brothers Neurosciences Institute Elk Grove Village Illinois
United States Elkhart Clinic, LLC Elkhart Indiana
United States Advanced Bio-Behavioral Sciences Elmsford New York
United States Pharmacology Research Institute Encino California
United States Associated Neurologists of Southern CT, P.C. Fairfield Connecticut
United States Precise Research Centers Flowood Mississippi
United States Advanced Neurosciences Research, LLC Fort Collins Colorado
United States Neurologic Consultants, P.A. Fort Lauderdale Florida
United States Clinical Physiology Associates, Inc. Fort Myers Florida
United States Emerald Coast Mood & Memory, PA. Fort Walton Beach Florida
United States Fort Wayne Neurological Center Fort Wayne Indiana
United States University of North Texas/Health Sciences Center-Fort Worth Fort Worth Texas
United States Psychiatric Consultants, PC Franklin Tennessee
United States Margolin Brain Institute Fresno California
United States Neuropsychiatric Research Center of Southwest Florida Ft. Myers Florida
United States Neurology Center of North Orange County Fullerton California
United States Integrated Medical and Behavioral Associates Glendale California
United States Dedicated Clinical Research, Inc. Goodyear Arizona
United States Saint Mary's Health Care Grand Rapids Michigan
United States Advanced Neurology Specialists Great Falls Montana
United States MD Clinical Hallandale Beach Florida
United States Hattiesburg Clinic Hattiesburg Mississippi
United States ActivMed Practices and Research, Inc Haverhill Massachusetts
United States Clinical Trials of America, Inc Hickory North Carolina
United States New Hope Clinical Research Hickory North Carolina
United States Sunrise Clinical Research, Inc. Hollywood Florida
United States Baylor College of Medicine Houston Texas
United States Claghorn-Lesem Research Clinic, Ltd. Houston Texas
United States Sun Valley Behavioral Medical Center Imperial California
United States Indiana University School of Medicine Indianapolis Indiana
United States Mayo Clinic College of Medicine Jacksonville Florida
United States The Clinical Trial Center, LLC Jenkintown Pennsylvania
United States East Tennessee State University Johnson City Tennessee
United States Borgess Medical Center/Borgess Research Institute Kalamazoo Michigan
United States Kansas Multi-Specialist Group Kansas City Kansas
United States Saint Luke's Hospital, Mid America Brain and Stroke Institute Kansas City Missouri
United States The Center for Pharmaceutical Research Kansas City Missouri
United States University of Kansas Medical Center Kansas City Kansas
United States Volunteer Research Group Knoxville Tennessee
United States Coordinated Clinical Research La Jolla California
United States University of California San Diego/Shela Marcos Alzheimer's Disease Research Center La Jolla California
United States Senior Clinical Trials Laguna Hills California
United States Lake Charles Clinical Trials Lake Charles Louisiana
United States Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada
United States Empire Neurology, PC Latham New York
United States Gwinnett Medical Center Lawrenceville Georgia
United States Dartmouth Hitchcock Medical Center, Dept of Neurology Lebanon New Hampshire
United States Mid America Neuroscience Institute Lenexa Kansas
United States Associates in Neurology, PSC Lexington Kentucky
United States University of Kentucky Lexington Kentucky
United States Clinical Trials Inc. Little Rock Arkansas
United States Neurological Care of CNY Liverpool New York
United States Collaborative Neuroscience Network Long Beach California
United States Pharmacology Research Institute Los Alamitos California
United States UCLA Department of Neurology Los Angeles California
United States Vintage Institute for Clinical Research, Inc Los Angeles California
United States University of Wisconson Medical School of Medicine and Public Health Madison Wisconsin
United States Neurology Associates Maitland Florida
United States Alzheimer's Research Corporation (ARC) Manchester New Jersey
United States Providence Medical Group-Medford Neurology Medford Oregon
United States Melbourne International Medicine Associates, MIMA Melbourne Florida
United States Allied Clinical Trials, Inc. Miami Florida
United States Miami Jewish Health Systems Miami Florida
United States Pharmax Research Clinic, LLC Miami Florida
United States Medical College of Wisconsin Milwaukee Wisconsin
United States The NeuroCognitive Institute Mount Arlington New Jersey
United States Medical University of South Carolina N. Charleston South Carolina
United States Synergy Research National City California
United States Institute for Neurodegenerative Disorders New Haven Connecticut
United States Yale University School of Medicine, Alzheimer's Disease Research Unit New Haven Connecticut
United States Parker Jewish Institute for Health Care & Rehabilitation New Hyde Park New York
United States Louisiana Research Associates, Inc. New Orleans Louisiana
United States Columbia University/Medical Center New York New York
United States Dent Neurologic Institute New York New York
United States Mt. Sinai School of Medicine New York New York
United States NYU School of Medicine/Psychiatry New York New York
United States Christiana Care Health Services Newark Delaware
United States Pharmacology Research Institute Newport Beach California
United States Neurocare, Inc. Newton Massachusetts
United States Research Center for Clinical Studies, Inc Norwalk Connecticut
United States Renstar Medical Research Ocala Florida
United States The Neurology Center Oceanside California
United States Lynn Health Science Institute Oklahoma City Oklahoma
United States Red River Medical Research Center, LLC Oklahoma City Oklahoma
United States University of Nebraska Medical Center Omaha Nebraska
United States University of California, Irvine Medical Center Orange California
United States Medical Research Group of Central Florida Orange City Florida
United States Nathan S. Kline Institute for Psychiatric Research Orangeburg New York
United States Compass Research, LLC Orlando Florida
United States Four Rivers Clinical Research Paducah Kentucky
United States Palm Beach Neurological Center/Advanced Research Consultants Palm Beach Gardens Florida
United States Neuro-Therapeutics Inc. Pasadena California
United States Broward Research Group, Inc. Pembroke Pines Florida
United States Methodist Medical Center of Illinois Peoria Illinois
United States Drexel University College of Medicine Philadelphia Pennsylvania
United States Jefferson Hospital for Neuroscience Philadelphia Pennsylvania
United States Penn Memory Center Philadelphia Pennsylvania
United States Banner Alzheimer's Institute Phoenix Arizona
United States HOPE Research Institute, LLC Phoenix Arizona
United States Clinical Trials Research Services, LLC Pittsburg Pennsylvania
United States University of Pittsburgh Pittsburgh Pennsylvania
United States Neuroscience Research of the Berkshires Pittsfield Massachusetts
United States Donald S. Marks, MD, P.C. Plymouth Massachusetts
United States Neurostudies, Inc Port Charlotte Florida
United States Oregon Health & Sciences University Portland Oregon
United States Providence Health Service System, AD Center, Brain Institute Portland Oregon
United States Summit Research Group, Inc. Portland Oregon
United States Princeton Medical Institute Princeton New Jersey
United States Butler Hospital Providence Rhode Island
United States Rhode Island Hospital Providence Rhode Island
United States Raleigh Neurology Associates Raleigh North Carolina
United States The Southwest Institute for Clinical Research, Inc. Rancho Mirage California
United States Alliance Research Group, LLC Richmond Virginia
United States Mayo Clinic Rochester Minnesota
United States University of Rochester Medical Center @ Monroe Community Hospital Rochester New York
United States CBH Health, LLC Rockville Maryland
United States Sutter Neuroscience Medical Group Sacramento California
United States University of California, Davis, Alzheimer's Disease Center Sacramento California
United States University of Utah, Dept of Neurology Salt Lake City Utah
United States Wasatch Clinical Research Salt Lake City Utah
United States Innovative Clinical Trials San Antonio Texas
United States Integra Clinical Research, LLC San Antonio Texas
United States Artemis Institute for Clinical Research San Diego California
United States Sharp Mesa Vista Hospital San Diego California
United States San Francisco Clinical Research Center San Francisco California
United States University of California, San Francisco San Francisco California
United States Neuropsychiatric Research Center of Orange County Santa Ana California
United States Neurological Research Institute Santa Monica California
United States Roskamp Institute Sarasota Florida
United States Maine Medical Partners Neurology Scarborough Maine
United States Pacific Medical Centers Seattle Washington
United States University of Washington Veterans Affairs Seattle Washington
United States Schuster Medical Research Institute Sherman Oaks California
United States J. Gary Booker, MD, APMC Shreveport Louisiana
United States Louisana State University Health Sciences Center Shreveport Louisiana
United States Avera Research Institute Sioux Falls South Dakota
United States Miami Research Associates South Miami Florida
United States Memory Wellness Clinic Springfield Massachusetts
United States Southern Illinois University, School of Medicine Springfield Illinois
United States Springfield Neurology Associates Springfield Massachusetts
United States Suncoast Neuroscience Associates, Inc. St Petersburg Florida
United States St. Louis University School of Medicine St. Louis Missouri
United States Washington University School of Medicine St. Louis Missouri
United States Meridien Research St. Petersburg Florida
United States University of Medicine and Dentistry of New Jersey Stratford New Jersey
United States Banner Research Institute Sun City Arizona
United States Axiom Clinical Research of Florida Tampa Florida
United States Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute Tampa Florida
United States Stedman Clinical Trials Tampa Florida
United States University of South Florida Suncoast Alzheimer's and Gerontology Center Tampa Florida
United States Neurology and Neuroscience Center of Ohio Toledo Ohio
United States Shore Neurology, P.A. Toms River New Jersey
United States Northwest Neurospecialists, PLLC Tucson Arizona
United States University of Arizona College of Medicine, Health Science Center Tucson Arizona
United States Diablo Clinical Research, Inc Walnut Creek California
United States Georgetown University Medical Center Washington District of Columbia
United States Chase Medical Research, LLC Waterbury Connecticut
United States Independent Pyschiatric Consultants Waukesha Wisconsin
United States Wenatchee Valley Medical Center Wenatchee Washington
United States Premiere Research Institute West Palm Beach Florida
United States Coastal Research Associates, Inc. Weymouth Massachusetts
United States Grayline Clinical Drug Trials, Inc Wichita Falls Texas
United States Wake Forest University Health Sciences Winston-Salem North Carolina

Sponsors (2)

Lead Sponsor Collaborator
JANSSEN Alzheimer Immunotherapy Research & Development, LLC Pfizer

Countries where clinical trial is conducted

United States,  Austria,  Canada,  Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cognitive and Functional 18 months No
Secondary Cognitive and Global 18 months No
Secondary Imaging and biochemical biomarkers of disease status 18 months No
See also
  Status Clinical Trial Phase
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Withdrawn NCT03316898 - A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease Phase 1
Withdrawn NCT02860065 - CPC-201 Alzheimer's Disease Type Dementia: PET Study Phase 2
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Recruiting NCT05607615 - A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease Phase 2
Terminated NCT03307993 - Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease Phase 1
Recruiting NCT02912936 - A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease N/A
Active, not recruiting NCT02899091 - Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease Phase 1/Phase 2
Completed NCT02907567 - Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease Phase 1/Phase 2
Not yet recruiting NCT02868905 - Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women N/A
Terminated NCT02521558 - Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease N/A
Completed NCT02516046 - 18F-AV-1451 Autopsy Study Phase 3
Completed NCT02580305 - SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study Phase 2
Recruiting NCT02247180 - Cognitive Rehabilitation in Alzheimer`s Disease N/A
Completed NCT02317523 - Alzheimer's Caregiver Coping: Mental and Physical Health N/A
Completed NCT02256306 - The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study N/A
Terminated NCT02220738 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors Phase 1
Completed NCT02260167 - Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol N/A
Completed NCT01920672 - Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of AD N/A